ClinicalTrials.gg
Sign In

Cardiotoxicity clinical trials

The registry lists 262 studies for Cardiotoxicity across more than 10 countries. 75 are recruiting or about to start. 116 of them are mainly about Cardiotoxicity (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Cardiotoxicity studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
93
Status unknown
57
Recruiting
51
Not yet recruiting
21
Terminated
21
Active, not recruiting
15

Phase

Phase 2
35
Phase 3
24
Phase 4
10
Phase 1
10
Early Phase 1
1

Where

United States
71
Canada
25
France
21
China
16
United Kingdom
15
Italy
14

Who runs them

Abramson Cancer Center at Penn Medicine (10) · Memorial Sloan Kettering Cancer Center (5) · University College, London (5) · Children's Oncology Group (5) · Groupe Hospitalier Pitie-Salpetriere (5) · Ain Shams University (4) · Peking University Third Hospital (4) · Washington University School of Medicine (4)

What is being tested here

Drugs under test in Cardiotoxicity studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Carvedilol237
Dexrazoxane247
Doxorubicin115
Atorvastatin114
Dapagliflozin102
Spironolactone102
Sacubitril valsartan102
Vincristine101
Polatuzumab vedotin101
Nicorandil101

Drug classes tested here Beta blockers 2 open · SGLT2 inhibitors 2 open · Statins 2 open · ACE inhibitors 1 open · Antimitotic agents 1 open

Coming up

6phase 3 studies under way
21studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 51 Cardiotoxicity studies recruiting now, 38 (75%) set no upper age limit and 8 (16%) stop at 75 or younger. 7 (14%) take children under 18. 15 (29%) are for women only and 0 (0%) for men only; 3 (6%) take healthy volunteers.

Recruiting studies that take each age, of 51
AgeWomenMen
105 (10%)4 (8%)
1847 (92%)33 (65%)
3047 (92%)33 (65%)
4046 (90%)32 (63%)
5045 (88%)31 (61%)
6547 (92%)32 (63%)
7544 (86%)30 (59%)
8541 (80%)29 (57%)

Across all 262 studies, recruiting or not: 25% stop at 75 or younger and 15% at 65; 15% take children; 29% are for women only and 2% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cardiotoxicity studies take

Of 71 observational studies under Cardiotoxicity, half reached primary completion within 69 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase52 mo35–73 · 48 studies—52 mo35–73 · 48 studies
Observational69 mo33–122 · 71 studies—69 mo33–122 · 69 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 262. Browse all 262 → or search them.